Developing kinase inhibitors for autoimmune disease, fibrosis and solid tumors.
Industry: Health Care
First Day Return: -19.2%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 06/10/2016 |
Offer Price | $12.00 |
Price Range $12.00 - $12.00 | |
Offer Shares (mm) | 6.3 |
Deal Size ($mm) | $75 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 07/26/2016 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $75 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | New York, NY, United States |
Founded | 2009 |
Employees at IPO | 138 |
Website www.kadmon.com |